{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:13:29Z","timestamp":1776356009991,"version":"3.51.2"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005727","name":"Universidade de Coimbra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12871-018-0585-6","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T23:03:12Z","timestamp":1536102192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients \u2013 a retrospective observational study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-5251","authenticated-orcid":false,"given":"Lu\u00eds","family":"Cabral","sequence":"first","affiliation":[]},{"given":"Vera","family":"Afreixo","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Meireles","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Vaz","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Tourais","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Chaves","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Artur","family":"Paiva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"585_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/TCRM.S119938","volume":"13","author":"O Nunes Lopez","year":"2017","unstructured":"Nunes Lopez O, Cambiaso-Daniel J, Branski LK, Norbury WB, Herndon DH. Predicting and managing sepsis in burn patients: current perspectives. Ther Clin Risk Manag. 2017;13:1107\u201317. \n                    https:\/\/doi.org\/10.2147\/TCRM.S119938\n                    \n                  .","journal-title":"Ther Clin Risk Manag"},{"key":"585_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41038-017-0089-5","volume":"5","author":"DG Greenhalgh","year":"2017","unstructured":"Greenhalgh DG. Sepsis in the burn patient: a different problem than sepsis in the general population. Burns & Trauma. 2017;5:23\u201333. \n                    https:\/\/doi.org\/10.1186\/s41038-017-0089-5\n                    \n                  .","journal-title":"Burns & Trauma"},{"key":"585_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/sur.2013.134","volume":"17","author":"W Norbury","year":"2016","unstructured":"Norbury W, Herndon DH, Tanksley J, Jeschke M, et al. Infections in burns. Surg Infect. 2016;17:250\u20135. \n                    https:\/\/doi.org\/10.1089\/sur.2013.134\n                    \n                  .","journal-title":"Surg Infect"},{"key":"585_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/2321-3868.135479","volume":"2","author":"H Jin","year":"2014","unstructured":"Jin H. Liu z, Xiao Y, fan X et al. prediction of sepsis in trauma patients. Burns & Trauma. 2014;2:106\u201313. \n                    https:\/\/doi.org\/10.4103\/2321-3868.135479\n                    \n                  .","journal-title":"Burns & Trauma"},{"key":"585_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/SHK.0000000000000497","volume":"45","author":"M Ru\u00edz-Caestilla","year":"2016","unstructured":"Ru\u00edz-Caestilla M, Roca O, Masclans JR, Barret JP. Recent advances in biomarkers in severe burns. Shock. 2016;45:117\u201325. \n                    https:\/\/doi.org\/10.1097\/SHK.0000000000000497\n                    \n                  .","journal-title":"Shock"},{"key":"585_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s15010-016-0965-0","volume":"45","author":"R Arora","year":"2017","unstructured":"Arora R, Campbell JP, Simon G, Sahni N. Does serum procalcitonin aid in the diagnosis of bloodstream infection regardless of whether patients exhibit the systemic inflammatory response syndrome? Infection. 2017;45:291\u20138. \n                    https:\/\/doi.org\/10.1007\/s15010-016-0965-0\n                    \n                  .","journal-title":"Infection"},{"key":"585_CR7","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/cc8872","volume":"14","author":"C Pierrakos","year":"2010","unstructured":"Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14:R15. \n                    https:\/\/doi.org\/10.1186\/cc8872\n                    \n                  .","journal-title":"Crit Care"},{"key":"585_CR8","doi-asserted-by":"publisher","unstructured":"Charles PE, Kus E, Aho S, et al. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report. BMC Infect Dis. 2009;9(49) \n                    https:\/\/doi.org\/10.1186\/1471-2334-9-4\n                    \n                  .","DOI":"10.1186\/1471-2334-9-4"},{"key":"585_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s13054-014-0529-6","volume":"18","author":"PE Marik","year":"2014","unstructured":"Marik PE. Don\u2019t miss the diagnosis of sepsis! Crit Care. 2014;18:529\u201330. \n                    https:\/\/doi.org\/10.1186\/s13054-014-0529-6\n                    \n                  .","journal-title":"Crit Care"},{"key":"585_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1776-1_16","volume-title":"Sepsis: Diagnostic Methods and Protocols, Methods Mol Biol","author":"JL Vincent","year":"2015","unstructured":"Vincent JL, van Nuffelen M, Lelubre C. Host response biomarkers in sepsis: the role of procalcitonin. In: Mancini N, editor. Sepsis: Diagnostic Methods and Protocols, Methods Mol Biol, vol. 1237. New York: \u00a9 Springer Science+Business Media; 2015. \n                    https:\/\/doi.org\/10.1007\/978-1-4939-1776-1_16\n                    \n                  ."},{"key":"585_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3343\/alm.2014.34.4.263","volume":"34","author":"M Meisner","year":"2014","unstructured":"Meisner M. Update on procalcitonin measurements. Annals of Laboratory Medicine. 2014;34:263\u201373. \n                    https:\/\/doi.org\/10.3343\/alm.2014.34.4.263\n                    \n                  .","journal-title":"Annals of Laboratory Medicine"},{"key":"585_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","volume":"21","author":"SH Hoeboer","year":"2015","unstructured":"Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21:474\u201381. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2014.12.026\n                    \n                  .","journal-title":"Clin Microbiol Infect"},{"key":"585_CR13","doi-asserted-by":"publisher","first-page":"e0129450","DOI":"10.1371\/journal.pone.0129450","volume":"10","author":"D Liu","year":"2015","unstructured":"Liu D, Su L, Han G, et al. Prognostic value of procalcitonin in adult patients with sepsis: a systematic review and meta-analysis. PLoS One. 2015;10:e0129450. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0129450.","journal-title":"PLoS One"},{"key":"585_CR14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1164\/rccm.201410-1895ED","volume":"190","author":"JL Vincent","year":"2014","unstructured":"Vincent JL, Teixeira L. Sepsis biomarkers. Value and limitations. Am J Respir Crit Care Med. 2014;190:1081\u20132. \n                    https:\/\/doi.org\/10.1164\/rccm.201410-1895ED\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"key":"585_CR15","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/ebch.1927","volume":"8","author":"P Schuetz","year":"2013","unstructured":"Schuetz P, M\u00fcller B, Christ-Crain M, Stolz D, et al. Procalcitonin to initiate or discontinue antibiotics in acute care respiratory tract infections. Evid-Based Child Health. 2013;8:1297\u2013371. \n                    https:\/\/doi.org\/10.1002\/ebch.1927\n                    \n                  .","journal-title":"Evid-Based Child Health"},{"key":"585_CR16","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/cc12787","volume":"17","author":"P Schuetz","year":"2013","unstructured":"Schuetz P, Maurer P, Punjabi V, Desai A, et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17:R115. \n                    https:\/\/doi.org\/10.1186\/cc12787\n                    \n                  .","journal-title":"Crit Care"},{"key":"585_CR17","doi-asserted-by":"publisher","first-page":"e0138150","DOI":"10.1371\/journal.pone.0138150","volume":"10","author":"JA Ryu","year":"2015","unstructured":"Ryu JA, Yang JH, Lee D, Suh GY, et al. Clinical uselfulness of procalcitonin and C-reactive protein as outcome predictors in critically patients with severe sepsis and septic schock. PLoS One. 2015;10:e0138150. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0138150\n                    \n                  .","journal-title":"PLoS One"},{"issue":"9713","key":"585_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, Cracco C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463\u201374. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)61879-1\n                    \n                  . 20097417","journal-title":"Lancet"},{"key":"585_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/bja\/aei143","volume":"94","author":"D Mokart","year":"2005","unstructured":"Mokart D, Merlin M, Sannini A, Brun JP, et al. Procalcitonin, Interleucin 6 and systemic inflammatory response syndrome (SIRS): early markers of sepsis after major surgery. Br J Anaesth. 2005;94:767\u201373. \n                    https:\/\/doi.org\/10.1093\/bja\/aei143\n                    \n                  .","journal-title":"Br J Anaesth"},{"key":"585_CR20","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00595-015-1159-6","volume":"45","author":"ZC Meyer","year":"2015","unstructured":"Meyer ZC, Schreinemakers JM, de Waal RA, van der Laan L. Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit: a review. Surg Today. 2015;45:1091\u2013101. \n                    https:\/\/doi.org\/10.1007\/s00595-015-1159-6\n                    \n                  .","journal-title":"Surg Today"},{"key":"585_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.burns.2013.11.018","volume":"40","author":"L Seoane","year":"2014","unstructured":"Seoane L, Pertega S, Galeiras R, Astola I, Bouza T. Procalcitonin in the burn unit and the diagnosis of infection. Burns. 2014;40:223\u20139. \n                    https:\/\/doi.org\/10.1016\/j.burns.2013.11.018\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13054-016-1194-8","volume":"20","author":"PM Honore","year":"2016","unstructured":"Honore PM, Spapen HD. The struggle to differentiate inflammation from infection in severely burned patients: time to send better biomarkers into the arena? Crit Care. 2016;20:13. \n                    https:\/\/doi.org\/10.1186\/s13054-016-1194-8\n                    \n                  .","journal-title":"Crit Care"},{"key":"585_CR23","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/cc12787","volume":"17","author":"DG Greenhalgh","year":"2007","unstructured":"Greenhalgh DG, Saffle JR, Holmes JH, et al. American burn association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;17:R115. \n                    https:\/\/doi.org\/10.1186\/cc12787\n                    \n                  .","journal-title":"J Burn Care Res"},{"issue":"Suppl.2","key":"585_CR24","doi-asserted-by":"publisher","first-page":"ii33","DOI":"10.1093\/jac\/dkq523","volume":"66","author":"S Kibe","year":"2011","unstructured":"Kibe S. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl.2):ii33\u201340. \n                    https:\/\/doi.org\/10.1093\/jac\/dkq523\n                    \n                  .","journal-title":"J Antimicrob Chemother"},{"key":"585_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.emc.2016.09.004","volume":"35","author":"B Long","year":"2017","unstructured":"Long B, Koyfman A. Ready for prime time? Biomarkers in Sepsis. Emerg Med Clin North Am. 2017;35:109\u201322. \n                    https:\/\/doi.org\/10.1016\/j.emc.2016.09.004\n                    \n                  .","journal-title":"Emerg Med Clin North Am"},{"key":"585_CR26","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1586\/1744666X.2014.949675","volume":"10","author":"M Sandquist","year":"2014","unstructured":"Sandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 2014;10:1349\u201356. \n                    https:\/\/doi.org\/10.1586\/1744666X.2014.949675\n                    \n                  .","journal-title":"Expert Rev Clin Immunol"},{"key":"585_CR27","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/SLA.0000000000000759","volume":"261","author":"S Yan","year":"2015","unstructured":"Yan S, Tsurumi A, Que YA, Ryan CM, et al. Prediction of multiple infections after severe burn trauma: a prospective cohort control. Ann Surg. 2015;261:781\u201391. \n                    https:\/\/doi.org\/10.1097\/SLA.0000000000000759\n                    \n                  .","journal-title":"Ann Surg"},{"key":"585_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s41038-016-0059-3","volume":"4","author":"J Hazeldine","year":"2016","unstructured":"Hazeldine J, Hampson P, Lord JM. The diagnostic and prognostic value of systems biology research in major traumatic and thermal injury: a review. Burns & Trauma. 2016;4:33. \n                    https:\/\/doi.org\/10.1186\/s41038-016-0059-3\n                    \n                  .","journal-title":"Burns & Trauma"},{"key":"585_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10528-016-9785-2","volume":"55","author":"VL David","year":"2017","unstructured":"David VL, Ercisli MF, Rogobete AF, Boia ES, et al. Early prediction of sepsis incidence in critically ill patients using specific genetic polymorphisms. Biochem Genet. 2017;55:193\u2013203. \n                    https:\/\/doi.org\/10.1007\/s10528-016-9785-2\n                    \n                  .","journal-title":"Biochem Genet"},{"key":"585_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Holeckova K, Froidevaux C, Pittet D, et al. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396\u2013402. \n                    https:\/\/doi.org\/10.1164\/ajrccm.164.3.2009052\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"key":"585_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","volume":"7","author":"BM Tang","year":"2007","unstructured":"Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systemic review and meta-analysis. Lancet Infect Dis. 2007;7:210\u20137.","journal-title":"Lancet Infect Dis"},{"key":"585_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","volume":"13","author":"C Wacker","year":"2013","unstructured":"Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker of sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:426\u201335. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(13)70301-3\n                    \n                  .","journal-title":"Lancet Infect Dis"},{"key":"585_CR33","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/cc13908","volume":"18","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Huici-Moreno MJ, Gutierrez-Pizarraya A, L\u00f3pez I, et al. Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis. Crit Care. 2014;18:R116. \n                    https:\/\/doi.org\/10.1186\/cc13908\n                    \n                  .","journal-title":"Crit Care"},{"key":"585_CR34","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.4081\/ecj.2017.6877","volume":"13","author":"G Lippi","year":"2017","unstructured":"Lippi G, Montagnana M, Balboni F, Bellone A, et al. Academy of emergency medicine and Care-Society of Clinical Biochemestry and Clinical Molecular Biology consensus recommendations for clinical use of sepsis biomarkers in the emergency department. Emergency Care Journal. 2017;13:6877. \n                    https:\/\/doi.org\/10.4081\/ecj.2017.6877\n                    \n                  .","journal-title":"Emergency Care Journal"},{"key":"585_CR35","doi-asserted-by":"publisher","unstructured":"Sager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(15) \n                    https:\/\/doi.org\/10.10186\/s12916-017-0795-7\n                    \n                  .","DOI":"10.10186\/s12916-017-0795-7"},{"key":"585_CR36","doi-asserted-by":"publisher","first-page":"e10012022","DOI":"10.1371\/journal.pmed.1002022","volume":"13","author":"JL Vincent","year":"2016","unstructured":"Vincent JL. The clinical challenge of sepsis identification and monitoring. PLoS Med. 2016;13:e10012022. \n                    https:\/\/doi.org\/10.13711\/journal.pmed.1002022\n                    \n                  .","journal-title":"PLoS Med"},{"key":"585_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819\u201327. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(16)00053-0\n                    \n                  .","journal-title":"Lancet Infect Dis"},{"key":"585_CR38","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/archinternmed.2011.318","volume":"171","author":"P Schuetz","year":"2011","unstructured":"Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171:1322\u201331. \n                    https:\/\/doi.org\/10.1001\/archinternmed.2011.318\n                    \n                  .","journal-title":"Arch Intern Med"},{"key":"585_CR39","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1097\/01.CCM.0000240788.00292.F1","volume":"34","author":"Z Moln\u00e1r","year":"2006","unstructured":"Moln\u00e1r Z, Bog\u00e1r L. Let\u2019s go dynamic with procalcitonin. Crit Care Med. 2006;34:2687\u20138. \n                    https:\/\/doi.org\/10.1097\/01.CCM.0000240788.00292.F1\n                    \n                  .","journal-title":"Crit Care Med"},{"key":"585_CR40","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1164\/rccm.201410-1895ED","volume":"190","author":"JL Vincent","year":"2014","unstructured":"Vincent JL. Sepsis biomarkers \u2013 values and limitations. Am J Respir Crit Care Med. 2014;190:1081\u20132. \n                    https:\/\/doi.org\/10.1164\/rccm.201410-1895ED\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"key":"585_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5114\/aoms.2016.57587","volume":"12","author":"M Lipinska-Gediga","year":"2016","unstructured":"Lipinska-Gediga M, Mierzchata-Pasierb M, Durek G. Procalcitonin kinetics \u2013 prognostic and diagnostic significance in septic patients. Arch Med Sci. 2016;12:112\u20139. \n                    https:\/\/doi.org\/10.5114\/aoms.2016.57587\n                    \n                  .","journal-title":"Arch Med Sci"},{"key":"585_CR42","first-page":"104","volume":"28","author":"D Trasy","year":"2017","unstructured":"Trasy D, Molnar Z. Procalcitonin \u2013 assisted antibiotic strategy in sepsis. J Int Fed Clin Chem. 2017;28:104\u201313. 28757818","journal-title":"J Int Fed Clin Chem"},{"key":"585_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/CCM.0000000000002321","volume":"45","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, Robert Birkhahn R, Robert Sherwin R, Jones AE, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring sepsis (MOSES) study. Crit Care Med. 2017;45:781\u20139. \n                    https:\/\/doi.org\/10.1097\/CCM.0000000000002321\n                    \n                  .","journal-title":"Crit Care Med"},{"key":"585_CR44","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s001340050644","volume":"24","author":"M Meisner","year":"1998","unstructured":"Meisner M, Tschaikowsky K, Hutzler A, Schick C, Sch\u00fcttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 1998;24:680\u20134. 9722037","journal-title":"Intensive Care Med"},{"key":"585_CR45","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/cc5067","volume":"10","author":"C Sponholz","year":"2006","unstructured":"Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 2006;10:R145. \n                    https:\/\/doi.org\/10.1186\/cc5067\n                    \n                  .","journal-title":"Crit Care"},{"key":"585_CR46","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.amjsurg.2012.11.024","volume":"206","author":"J Friederichs","year":"2013","unstructured":"Friederichs J, Hutter M, Hierholzer C, Novotny A, et al. Procalcitonin as a predictor of successful surgical treatment of severe necrotizing soft tissue infections. Am J Surg. 2013;206:368\u201373. \n                    https:\/\/doi.org\/10.1016\/j.amjsurg.2012.11.024\n                    \n                  .","journal-title":"Am J Surg"},{"key":"585_CR47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jamcollsurg.2016.01.059","volume":"222","author":"JL Mu\u00f1oz","year":"2016","unstructured":"Mu\u00f1oz JL, Ruiz-Tovar J, Miranda E, Berrio DL, et al. C-reactive protein and procalcitonin as early markers of septic complications after laparoscopic sleeve gastrectomy in morbidly obese patients with an enhanced recovery after surgery program. J Am Coll Surg. 2016;222:831\u20137. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.01.059\n                    \n                  .","journal-title":"J Am Coll Surg"},{"key":"585_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.avsg.2016.01.012","volume":"34","author":"G Varetto","year":"2016","unstructured":"Varetto G, Castagno C, Trucco A, Frola E, et al. Serum procalcitonin as a valuable diagnostic tool in the early detection of infectious complications after abdominal aortic repair. Ann Vasc Surg. 2016;34:111\u20138. \n                    https:\/\/doi.org\/10.1016\/j.avsg.2016.01.012\n                    \n                  .","journal-title":"Ann Vasc Surg"},{"issue":"e9496","key":"585_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MD.00000000000009496","volume":"3","author":"S Spoto","year":"2018","unstructured":"Spoto S, Valeriani E, Caputo D, Cella E, et al. The role of procalcitonin in the diagnosis of bacterial infection after major abdominal surgery - advantage from daily measurement. Medicine. 2018;3(e9496):97. \n                    https:\/\/doi.org\/10.1097\/MD.00000000000009496\n                    \n                  .","journal-title":"Medicine"},{"key":"585_CR50","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.burns.2006.10.401","volume":"33","author":"L Bargues","year":"2007","unstructured":"Bargues L, Chancerelle Y, Catineau J, Jault P, Carsin H. Evaluation of serum procalcitonin concentration in the ICU following severe burn. Burns. 2007;33:860\u20134. \n                    https:\/\/doi.org\/10.1016\/j.burns.2006.10.401\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR51","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.burns.2013.04.009","volume":"39","author":"L Schultz","year":"2013","unstructured":"Schultz L, Walker SA, Elligsen M, Walker SE. Identification of predictors of early infection in acute burn patients. Burns. 2013;39:1355\u201366. \n                    https:\/\/doi.org\/10.1016\/j.burns.2013.04.009\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.burns.2006.07.001","volume":"33","author":"A Lavrentieva","year":"2007","unstructured":"Lavrentieva A, Kontakiotis T, Lazaridis L, et al. Inflammatory markers in patients with severe burn injury: What is the best indicator of sepsis. Burns. 2007;33:189. \n                    https:\/\/doi.org\/10.1016\/j.burns.2006.07.001\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR53","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.burns.2008.01.014","volume":"34","author":"M Barati","year":"2008","unstructured":"Barati M, Alinejad F, Bahar MA, et al. Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns. 2008;34:770\u20134.","journal-title":"Burns"},{"key":"585_CR54","first-page":"116","volume":"28","author":"A Mokline","year":"2015","unstructured":"Mokline A, Garsallah L, Rahmani I, Jerbi K, et al. Procalcitonin: a diagnostic and prognostic biomarker of sepsis in burned patients. Ann Burns Fire Disasters. 2015;28:116\u201320. 27252609","journal-title":"Ann Burns Fire Disasters"},{"key":"585_CR55","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.burns.2017.03.026","volume":"43","author":"L Cabral","year":"2017","unstructured":"Cabral L, Afreixo V, Santos S, Almeida L, Paiva JA. Procalcitonin for the early diagnosis of sepsis in burn patients; a retrospective study. Burns. 2017;43:1427\u201334. \n                    https:\/\/doi.org\/10.1016\/j.burns.2017.03.026\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR56","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.burns.2010.04.013","volume":"37","author":"EA Mann","year":"2011","unstructured":"Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns. 2011;37:549\u201358. \n                    https:\/\/doi.org\/10.1016\/j.burns.2010.04.013\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR57","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.burns.2014.08.019","volume":"41","author":"H Ren","year":"2015","unstructured":"Ren H, Li Y, Han C, Hu H. Serum procalcitonin as a diagnostic biomarker for sepsis in burn patients: a meta-analysis. Burns. 2015;41:502\u20139. \n                    https:\/\/doi.org\/10.1016\/j.burns.2014.08.019\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR58","doi-asserted-by":"publisher","unstructured":"Cabral, V Afreixo, L Almeida, Paiva JA. The use of procalcitonin (PCT) for diagnosis of sepsis in burn patients: a meta-analysis. PLoS One 2016;11: e0168475. DOI:\n                    https:\/\/doi.org\/10.1371\/journal.pone.0168475\n                    \n                  .","DOI":"10.1371\/journal.pone.0168475"},{"key":"585_CR59","doi-asserted-by":"crossref","unstructured":"von Heimburg D, Stieghorst W, Khorram-Sefat R, Pallua N. Procalcitonin \u2013 a sepsis parameter in severe burn injuries. Burns 1998;24:745\u2013750. PMID:9915676.","DOI":"10.1016\/S0305-4179(98)00109-0"},{"key":"585_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00004630-199909000-00004","volume":"20","author":"C Sachse","year":"1999","unstructured":"Sachse C, Machens HG, Felmerer G, Berger A, Henkel E. Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. J Burn Care Rehabil. 1999;20:354\u201360. 10501320","journal-title":"J Burn Care Rehabil"},{"key":"585_CR61","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.injury.2013.09.024","volume":"44","author":"V Ciriello","year":"2013","unstructured":"Ciriello V, Gudipati S, Stavrou PZ, Kanakaris NK, et al. Biomarkers predicting sepsis in polytrauma patients: current evidence. Injury. 2013;44:1680\u201392. \n                    https:\/\/doi.org\/10.1016\/j.injury.2013.09.024\n                    \n                  .","journal-title":"Injury"},{"key":"585_CR62","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00268-008-9896-y","volume":"33","author":"A Billeter","year":"2009","unstructured":"Billeter A, Turina M, Seifert B, Mica L, et al. Early serum procalcitonin, interleukin-6 and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg. 2009;33:558\u201366. \n                    https:\/\/doi.org\/10.1007\/s00268-008-9896-y\n                    \n                  .","journal-title":"World J Surg"},{"key":"585_CR63","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.burns.2011.08.021","volume":"38","author":"A Lavrentieva","year":"2012","unstructured":"Lavrentieva A, Papadopoulou S, Kioumis J, Kaimakamis E, Bitzani M. PCT as a diagnostic and prognostic tool in burn patients - whether time course has a role in monitoring sepsis treatment. Burns. 2012;38:356\u201363. \n                    https:\/\/doi.org\/10.1016\/j.burns.2011.08.021\n                    \n                  .","journal-title":"Burns"},{"key":"585_CR64","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/229255031502300412","volume":"23","author":"JJ Egea Guerrero","year":"2015","unstructured":"Egea Guerrero JJ, Mart\u00ednez-Fernandez C, Rodr\u00edguez-Rodr\u00edguez A, Bohorquez-L\u00f3pez A, et al. The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: a preliminary study. Plastic Surgery. 2015;23:239\u201343. \n                    https:\/\/doi.org\/10.1177\/229255031502300412\n                    \n                  .","journal-title":"Plastic Surgery"},{"key":"585_CR65","first-page":"57","volume":"42","author":"HS Kim","year":"2012","unstructured":"Kim HS, Yang HT, Hur J, Chun W, et al. Procalcitonin levels within 48 hours after burn injury as a prognostic factor. Ann Clin Lab Sci. 2012;42:57\u201364. 22371911","journal-title":"Ann Clin Lab Sci"},{"key":"585_CR66","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/bja\/ael181","volume":"97","author":"AA Dahaba","year":"2006","unstructured":"Dahaba AA, Hagara B, Fall A, Rehak PH, et al. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth. 2006;97:503\u20138. \n                    https:\/\/doi.org\/10.1093\/bja\/ael181\n                    \n                  .","journal-title":"Br J Anaesth"},{"key":"585_CR67","doi-asserted-by":"publisher","first-page":"e0181704","DOI":"10.1371\/journal.pone.0181704","volume":"12","author":"L Ljungstr\u00f6m","year":"2017","unstructured":"Ljungstr\u00f6m L, Pernestig A-K, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One. 2017;12:e0181704. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0181704\n                    \n                  .","journal-title":"PLoS One"},{"key":"585_CR68","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2012.05.002","volume":"73","author":"S Riedel","year":"2012","unstructured":"Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis. 2012;73:221\u20137. \n                    https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.05.002\n                    \n                  .","journal-title":"Diagn Microbiol Infect Dis"},{"key":"585_CR69","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1471-2334-11-224","volume":"11","author":"N Bele","year":"2011","unstructured":"Bele N, Darmon M, Coquet I, Feugeas JP, et al. Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients. BMC Infect Dis. 2011;11:224. \n                    https:\/\/doi.org\/10.1186\/1471-2334-11-224\n                    \n                  .","journal-title":"BMC Infect Dis"},{"key":"585_CR70","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1586\/eri.10.25","volume":"8","author":"P Schuetz","year":"2010","unstructured":"Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti-Infect Ther. 2010;8:575\u201387. \n                    https:\/\/doi.org\/10.1586\/eri.10.25\n                    \n                  .","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"585_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1309\/AJCP4GV7ZFDTANGC","volume":"141","author":"T Hattori","year":"2014","unstructured":"Hattori T, Nishiyama H, Kato H, Ikegami S, et al. Clinical value of procalcitonin for patients with suspected bloodstream infections. Am J Clin Pathol. 2014;141:43\u201351. \n                    https:\/\/doi.org\/10.1309\/AJCP4GV7ZFDTANGC\n                    \n                  .","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"585_CR72","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S1473-3099(16)30258-4","volume":"16","author":"L Steuten","year":"2016","unstructured":"Steuten L, Mantjes G. Economic value of procalcitonin guidance. Lancet Infect Dis. 2016;16(9):1000. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(16)30258-4\n                    \n                  .","journal-title":"Lancet Infect Dis"},{"key":"585_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.chest.2016.06.046","volume":"151","author":"RA Balk","year":"2017","unstructured":"Balk RA, Kadri SS, Cao Z. Effect of procalcitonin testing on health-care utilization costs in critically ill patients in the United States. Chest. 2017;151:23\u201333. \n                    https:\/\/doi.org\/10.1016\/j.chest.2016.06.046\n                    \n                  .","journal-title":"Chest"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-018-0585-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12871-018-0585-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-018-0585-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T03:42:54Z","timestamp":1569037374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-018-0585-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1186\/s12871-018-0585-6","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"8 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has got the formal approval from the Ethics Committee of Coimbra University Hospital Centre (CHUC) to its realization. The Ethics Committee of Coimbra University Hospital Centre (CHUC) also waived the need for informed consent according to Declaration of Helsinki and CIOMS International Ethics Guidelines because this study was a retrospective observational study of patients from an anonymized dataset that only involved recording data from medical records.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data was anonymized, and this study does not contain any individual person\u2019s data in any form (including individual details, images or videos). Therefore, consent for publication was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"On behalf of all authors, the corresponding author states that they have have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"122"}}